Co-Diagnostics Operating Expenses Growth & History (CODX)

Co-Diagnostics's operating expenses was $50.6M for fiscal 2025.

View full Co-Diagnostics company overview

Co-Diagnostics annual operating expenses history

Co-Diagnostics annual operating expenses

Fiscal yearPeriod endedOperating expensesChangeGrowth
20252025-12-31$50.6M$7.6M+17.60%
20242024-12-31$43.0M−$2.3M−5.15%
20232023-12-31$45.3M−$10.4M−18.64%
20222022-12-31$55.7M$15.5M+38.44%
20212021-12-31$40.2M$24.0M+147.40%
20202020-12-31$16.3M$10.3M+171.30%
20192019-12-31$6.0M−$152,052−2.47%
20182018-12-31$6.1M$1.6M+34.49%
20172017-12-31$4.6M$2.9M+170.82%
20162016-12-31$1.7M

Co-Diagnostics operating expenses trends

Over the last five fiscal years, Co-Diagnostics's operating expenses increased from $16.3M to $50.6M, a change of $34.3M. The latest reported quarter, Q2 2026, shows $6.3M.

About the metric

What operating expenses mean

Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.

Calculation and source

SEC-reported and calculated operating expenses

TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Co-Diagnostics source filings ↗

Community posts

It’s quiet here.

No posts about CODX yet. Start the conversation.

Write the first post